They showed that MYL9 expression level was significantly increased in late stages (stages III and IV) of NSCLC, and expression level of MYL9 in NSCLC with lymphatic metastasis was significantly higher than that in NSCLC without lymphatic metastasis, thus suggesting that MYL9 may also be involved in NSCLC metastasis [18]. The gene discussed is MYL9; the disease is non-small cell lung carcinoma.